Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
9
Bearish filings
169
Named actors
17
Disclosed $ (bull / bear)
$9.4M / $211.5M + 23 of unknown size
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-10-15 | Director WILSON JAMES N | sold | $762K | SEC ↗ |
| 2026-10-15 | Director WILSON JAMES N | sold | $351K | SEC ↗ |
| 2026-10-15 | Director WILSON JAMES N | sold | $35K | SEC ↗ |
| 2026-10-02 | See Remarks Maduck Sean | sold | $1.8M | SEC ↗ |
| 2026-10-02 | See Remarks Maduck Sean | sold | $1.0M | SEC ↗ |
153 more disclosures in the window — the full record, scoring, and track-record evidence are for members.
Want the read, not just the record?
Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-10-02 |
| See Remarks Lyon Joseph Douglas |
| sold |
| $553K |
| SEC ↗ |
| 2026-10-02 | See Remarks Lyon Joseph Douglas | sold | $514K | SEC ↗ |
| 2026-10-02 | President, Oncology Vieira Roberto Wandenkolk | sold | $600K | SEC ↗ |
| 2026-10-02 | President, Oncology Vieira Roberto Wandenkolk | sold | $126K | SEC ↗ |
| 2026-10-02 | President, Oncology Vieira Roberto Wandenkolk | sold | $241K | SEC ↗ |
| 2026-10-01 | See Remarks Maduck Sean | sold | $48K | SEC ↗ |
| 2026-10-01 | See Remarks Lyon Joseph Douglas | sold | $93K | SEC ↗ |
| 2026-10-01 | Officer (via Stifel Nicolaus) Lyon Joseph Douglas | filed notice to sell | $1.2M | SEC ↗ |
| 2026-09-24 | Chief Business Officer Robb Gary Charles | gifted | — | SEC ↗ |
| 2026-09-17 | Chief Business Officer Robb Gary Charles | exercised options & held the shares | $145K | SEC ↗ |
| 2026-09-16 | President, Oncology Vieira Roberto Wandenkolk | sold | $30K | SEC ↗ |
| 2026-09-15 | Director WILSON JAMES N | sold | $750K | SEC ↗ |
| 2026-09-15 | Director WILSON JAMES N | sold | $313K | SEC ↗ |
| 2026-09-15 | Director WILSON JAMES N | sold | $44K | SEC ↗ |
| 2026-09-15 | Director (via THE CHARLES SCHWAB CORPORATION) WILSON JAMES N | filed notice to sell | $3.3M | SEC ↗ |
| 2026-09-14 | See Remarks Lyon Joseph Douglas | sold | $885K | SEC ↗ |
| 2026-09-14 | See Remarks Lyon Joseph Douglas | sold | $250K | SEC ↗ |
| 2026-09-14 | Officer (via Stifel Nicholas) Lyon Joseph Douglas | filed notice to sell | $1.1M | SEC ↗ |
| 2026-09-02 | President, Oncology Vieira Roberto Wandenkolk | sold | $2.6M | SEC ↗ |
| 2026-09-02 | President, Oncology Vieira Roberto Wandenkolk | sold | $141K | SEC ↗ |